Showing results (2571-2580 of 4,227) with videos related to

Sort By:
Pageof 423
Discover Oncology|November 18, 2025
Adenylosuccinate lyase (ADSL) is a pan-cancer prognostic and immune biomarker with distinct roles in hepatocellular carcinomaWeixiong Zhu, Xuefan Zeng, Jianqi Qin, et al.
Discover Oncology|December 30, 2025
Integrated transcriptomic and single-cell analysis reveals cell cycle dysregulation and cellular heterogeneity in lung cancerYuzi Zhang, Wencheng Che, Qingchuan Li, et al.
Discover Oncology|December 31, 2025
Transcription factor NRF2 and the expression of the Hippo pathway effector TAZ in bladder tumorigenesis are significantly correlatedMohammad Vahabirad, Hadi Ghasemi, Atefeh Pegah, et al.
Discover Oncology|December 27, 2025
The impact of tumor-associated inflammatory adhesions on survival and treatment strategies in patients with colon cancerJinzhu Zhang, Jichuan Quan, Shucheng Liu, et al.
Discover Oncology|December 25, 2025
The role of metabolites in the causal effect of immune cell phenotypes on immunotherapy toxicity riskMeng Tang, Fei Mu, Zhen Yan, et al.
Discover Oncology|February 2, 2026
Development and validation of a robust cuproptosis related signature for primary glioma via machine learning aided by loop training and validationYi Zheng, Pancheng Wu, Si Yang, et al.
Discover Oncology|December 25, 2025
CTHRC1/TGF-β/Smad axis serves as therapeutic targets in inhibiting oral squamous cell carcinoma by mediating ferroptosisShihao Huang, Yiming Jiao, Yongchun Chang, et al.
Discover Oncology|December 19, 2025
Hotspots and frontiers of the relationship between hepatocellular carcinoma and cancer-associated fibroblasts: a bibliometric analysis and reviewHuixia Zheng, Lingling Ren, Guanglan Chen, et al.
Discover Oncology|December 25, 2025
Nrf2 functions as a biomarker and therapeutic target in lung cancer based on bibliometric analysis and molecular mechanismsHaixia Fan, Shudan Deng, Limantian Wang, et al.
Discover Oncology|January 13, 2026
Abnormal PLK2 expression is associated with specific subtypes and may help risk stratification in acute myeloid leukemiaQin Chen, Zijun Xu, Tingting Du, et al.
Pageof 423